GLP-1 Receptor Agonists: A Game-Changing Discovery for Mast Cell Activation Syndrome
As a functional medicine physician, I’m always looking for innovative solutions to complex chronic conditions like Mast Cell Activation Syndrome (MCAS). Today, I’m sharing a discovery that could truly revolutionize patient care—a connection that emerged from an unexpected source: diabetes medications.
Details















